Research progress in the treatment of small cell neuroendocrine cervical carcinoma
10.3969/j.issn.1672-8467.2025.01.017
- VernacularTitle:宫颈小细胞神经内分泌癌治疗的研究进展
- Author:
Xue-song XIANG
1
;
Jing-xin DING
1
Author Information
1. 复旦大学附属妇产科医院妇科肿瘤科 上海 200090
- Publication Type:Journal Article
- Keywords:
uterine cervical cancer;
small cell neuroendocrine carcinoma(SCNECC);
combined modality therapy
- From:
Fudan University Journal of Medical Sciences
2025;52(1):128-132
- CountryChina
- Language:Chinese
-
Abstract:
Small cell neuroendocrine cervical carcinoma(SCNECC)is a rare gynecological malignancy characterized by early invasion and metastasis,resulting in a poorer prognosis compared to cervical squamous cell carcinoma and adenocarcinoma.The clinical management of SCNECC remains in the exploratory phase.Recently,as this uncommon tumor has garnered increasing attention both domestically and internationally,some progress has been made in improving its prognosis.This article summarizes the advancements in combined modality therapy for SCNECC,discussing and providing insights into key issues related to current treatment strategies of surgery,radiotherapy and chemotherapy,as well as targeted and immunotherapies.
